Clinical trial
Natural Killer Index From Hematopoietic Stem Cell Graft
NCT00435864 · Nantes University Hospital, Other · Completed
Key facts
| NCT number | NCT00435864 |
|---|---|
| Title | Natural Killer Index From Hematopoietic Stem Cell Graft |
| Official title | Pilot, Multicenter and Prospective Study of the Natural Killer Index From Hematopoietic Stem Cell Graft at a Genotypic, Phenotypic and Functional Level |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Chronic Myeloid Leukemia |
| Intervention type | Procedure |
| Interventions | Blood test |
| Enrollment | 92 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Feb 16, 2007 |
| Last update posted | Apr 30, 2014 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: